ANAHEIM  CA--(Marketwired - Nov 15  2017) - BioCorRx  Inc (OTCQB: BICX) (the "Company")  a developer and provider of advanced solutions in the treatment of alcohol and opioid addiction  today announced that it has entered into a confidentiality agreement with the National Institute on Drug Abuse (NIDA)  a United States federal-government research institute whose mission is "to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health